Correlation Between Monopar Therapeutics and TechPrecision Common

Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and TechPrecision Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and TechPrecision Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Monopar Therapeutics and TechPrecision Common, you can compare the effects of market volatilities on Monopar Therapeutics and TechPrecision Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of TechPrecision Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and TechPrecision Common.

Diversification Opportunities for Monopar Therapeutics and TechPrecision Common

0.08

Correlation Coefficient

Monopar Therapeutics  TechPrecision Common

Significant diversification

The 3 months correlation between Monopar and TechPrecision is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and TechPrecision Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TechPrecision Common and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with TechPrecision Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TechPrecision Common has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and TechPrecision Common go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and TechPrecision Common

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 2.86 times less return on investment than TechPrecision Common. But when comparing it to its historical volatility, Monopar Therapeutics is 1.02 times less risky than TechPrecision Common. It trades about 0.07 of its potential returns per unit of risk. TechPrecision Common is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  323.00  in TechPrecision Common on May 10, 2025 and sell it today you would earn a total of  224.00  from holding TechPrecision Common or generate 69.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Monopar Therapeutics  vs.  TechPrecision Common

Monopar Therapeutics

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

TechPrecision Common

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in TechPrecision Common are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile fundamental indicators, TechPrecision Common unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Monopar Therapeutics and TechPrecision Common

The main advantage of trading using opposite Monopar Therapeutics and TechPrecision Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, TechPrecision Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TechPrecision Common will offset losses from the drop in TechPrecision Common's long position.

The idea behind Monopar Therapeutics and TechPrecision Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.